资讯

TAMPA, Fla., Aug. 28, 2025 /PRNewswire/ -- Crown Holdings, Inc., (NYSE: CCK) (Crown) (www.crowncork.com), a leading global packaging supplier, announced today that its updated near-term and new ...
CHARLOTTE, N.C., Aug. 21, 2025 /PRNewswire/ -- Honeywell (NASDAQ: HON) today announced the filing of its Form 10 registration statement ("Form 10") with the U.S. Securities and Exchange Commission ...
Let‘s start by dispensing with the notion that Austin Dillon ever will be known as the imitator of “The Intimidator.” The current driver of the No. 3 Chevrolet has six victories in 433 Cup starts and ...
1 Laboratory for the Study of the Well-Being of Families and Couples, Department of Psychology, Université du Québec à Montréal, Montreal, QC, Canada 2 Trauma and Couples Research and Intervention ...
Abstract: StrideSync is an innovative solution that enhances fitness tracking and nutritional analysis through advanced AI and computer vision technologies. As personal fitness and dietary management ...
An understanding of the nature and function of human trust in artificial intelligence (AI) is fundamental to the safe and effective integration of these technologies into organizational settings. The ...
Cybersecurity researchers are calling attention to a new type of credential phishing scheme that ensures that the stolen information is associated with valid online accounts. The technique has been ...
This is a modern, animated Login Form with JavaScript validation. It ensures a smooth user experience with real-time validation, error handling, and responsive design ...
Sherlock Holmes is famous for his incredible ability to sort through mounds of information; he removes the irrelevant and exposes the hidden truth. His philosophy is plain yet brilliant: "When you ...
Abstract: We present TURBOTV, a translation validator for the JavaScript (JS) just-in-time (JIT) compiler of V8. WhileJS engines have become a crucial part of various software systems, their emerging ...
Educating a diverse group of women in Los Angeles County on ovarian and uterine cancers and clinical trials.